Issue #3 — Theranos: The Board That Was Built Not To Ask
Theranos had one of the most prestigious boards in America, and one of the least effective. A study of how the board’s missing oversight enabled the fraud, and what it teaches about building boards that verify rather than vouch.
The Rise of the “Fractional Specialist”: Why Legal Teams Are Quietly Rewriting Their Hiring Playbook
By: Daniel Santos, Special Counsel | May 29, 2026 Daniel Santos Helping Healthtech CEOs &…
Not Good: Bad Acts, BIG Costs Issue #2 — Dieselgate: Ten Monkeys, One Beetle, and Cartoons
In Issue #2 of Not Good, Kevin Brenner examines Dieselgate — how Volkswagen’s defeat-device software, an industry-funded monkey exhaust study, and years of concealment from regulators produced over $25 billion in penalties, multiple prison sentences, and a lasting lesson in what happens when compliance risk becomes personal risk.
The New Board Question: “What’s Our Exposure to AI‑Driven Misconduct?”
Two companies, same AI tools, totally different risk profiles. Daniel Santos on the new board question — “What’s our exposure to AI-driven misconduct?” — and why AI accountability, not technology, decides whether your governance holds up under scrutiny.
Red Flag: The Vendor Requested Far More PHI Than the Service Required
A vendor deal that looked routine — clean MSA, sensible pricing, BAA already in place — almost moved forward in minutes. Then the SOW revealed a PHI request far beyond what was actually needed. Robyn D. Marino on why HIPAA compliance doesn’t stop at the BAA, and how SOW-level review changes the risk calculus on healthcare vendor agreements.
Do we still need to care about the FCPA?
By: Kevin Brenner, Esquire I’m hearing a surprising version of the same question from clients…
The Fastest Way to Break Compliance? Make Everyone Responsible.
Healthcare compliance accountability is the difference between organizations where compliance moves with the business —…
Health Tech Founders Don’t Need More Legal Warnings. They Need Better Thinking
Most content from law firms follows a predictable pattern: highlight a new regulation, point out…
